These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25055075)

  • 1. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
    Toniolo Neto J
    Sao Paulo Med J; 2014; 132(4):256-7. PubMed ID: 25055075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: Neuraminidase inhibitors reduce symptomatic influenza; oseltamivir does not reduce hospitalizations.
    Millard PS
    Ann Intern Med; 2014 Oct; 161(8):JC2. PubMed ID: 25329219
    [No Abstract]   [Full Text] [Related]  

  • 3. Should neuraminidase inhibitors be prescribed for patients with influenza?
    Patel DM; Pitts SR; Hargraves J
    Ann Emerg Med; 2014 Jan; 63(1):54-5. PubMed ID: 23932720
    [No Abstract]   [Full Text] [Related]  

  • 4. Oseltamivir and zanamivir have limited effect on symptoms and do not reduce hospitalisation or serious complications of influenza.
    Ebell MH
    Evid Based Med; 2014 Dec; 19(6):211. PubMed ID: 24985901
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuraminidase inhibitors for preventing and treating influenza in children.
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD002744. PubMed ID: 22513907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitors for influenza.
    Krumholz HM
    BMJ; 2014 Apr; 348():g2548. PubMed ID: 24811413
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
    Jefferson T; Jones MA; Doshi P; Del Mar CB; Heneghan CJ; Hama R; Thompson MJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008965. PubMed ID: 22258996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of neuraminidase inhibitors for severe influenza.
    Fry AM
    Lancet Respir Med; 2014 May; 2(5):346-8. PubMed ID: 24815800
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
    Jefferson T; Jones M; Doshi P; Del Mar C; Dooley L; Foxlee R
    Cochrane Database Syst Rev; 2010 Feb; 2011(2):CD001265. PubMed ID: 20166059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase inhibitors for influenza treatment and prevention in healthy adults.
    Cayley WE
    Am Fam Physician; 2010 Aug; 82(3):242-4. PubMed ID: 20672786
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuraminidase inhibitors for influenza in healthy adults: what we don't know.
    Gupta D; Mootha VK
    Natl Med J India; 2010; 23(1):29-31. PubMed ID: 20839590
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Harnden AR; Perera R; Sheikh A; Symmonds-Abrahams M
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002744. PubMed ID: 17253479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 15. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
    Wolkewitz M; Schumacher M
    Lancet Respir Med; 2014 Jul; 2(7):e8-9. PubMed ID: 24948434
    [No Abstract]   [Full Text] [Related]  

  • 16. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
    Leonardi-Bee J; Venkatesan S; Muthuri SG; Nguyen-Van-Tam JS; Myles PR;
    Lancet Respir Med; 2014 Jul; 2(7):e10-2. PubMed ID: 24948433
    [No Abstract]   [Full Text] [Related]  

  • 17. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
    Jones M; Del Mar C; Hama R
    Lancet Respir Med; 2014 Jul; 2(7):e9-e10. PubMed ID: 24948431
    [No Abstract]   [Full Text] [Related]  

  • 18. Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.
    Antes G; Meerpohl JJ
    Lancet Respir Med; 2014 Jul; 2(7):e10. PubMed ID: 24948429
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controversies about neuraminidase inhibitor. Is the influenza drug less effective than assumed?].
    Haas W
    MMW Fortschr Med; 2010 Jan; 152(3):7. PubMed ID: 20333956
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.
    Shun-Shin M; Thompson M; Heneghan C; Perera R; Harnden A; Mant D
    BMJ; 2009 Aug; 339():b3172. PubMed ID: 19666987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.